This country profile provides an overview of Angola’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
11%
Blinding trachoma
N/A
Intestinal worms
14%
Bilharzia
27%
River blindness
12%
2.31 million
people received treatment in Angola in 2019
13.05 million
people did not receive treatment in Angola in 2019
Elephantiasis
Treatment coverage increased from 1% in 2018 to 11% in 2019.
People needing treatment
2.39m
People receiving treatment
264k
Blinding trachoma
Angola does not require mass treatment for blinding trachoma.
Intestinal worms
Treatment coverage decreased from 25% in 2018 to 14% in 2019.
Pre sch and school-aged children needing treatment
12.19m
Pre sch and school-aged children receiving treatment
1.73m
Bilharzia
Treatment coverage decreased from 51% in 2018 to 27% in 2019.
School-aged children needing treatment
4.07m
School-aged children receiving treatment
1.12m
River blindness
Treatment coverage decreased from 20% in 2018 to 12% in 2019.
People needing treatment
5.76m
People receiving treatment
670k
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Angola.